Curated News: Medical Meetings

Filters close
Released: 31-Oct-2013 11:00 AM EDT
Fast, Painless Alternative to Liver Biopsies for Hepatitis Patients Proves Accurate, Reliable
Henry Ford Health

A non-invasive alternative to liver biopsy, now the standard method of diagnosing cirrhosis in hepatitis patients, proved very reliable in a national multi-center study including Henry Ford Hospital.

Released: 30-Oct-2013 4:50 PM EDT
Risk of Osteoporosis Drug’s Side Effects Not Significant, Loyola Researchers Find
Loyola Medicine

The risks of developing kidney failure and a calcium deficiency from the popular osteoporosis drug zoledronic acid are extremely rare, according to researchers at Loyola University Health System (LUHS). These findings were presented earlier this month at the American Society for Bone and Mineral Research’s annual meeting.

Released: 30-Oct-2013 11:00 AM EDT
Experts from NYU Langone Present New Research at American College of Rheumatology 2013 Annual Meeting
NYU Langone Health

Experts from NYU Langone’s Department of Medicine, Division of Rheumatology presented new research and participated in expert panel discussions at the American College of Rheumatology 2013 Annual Meeting in San Diego, CA, October 26-30.

Released: 30-Oct-2013 11:00 AM EDT
Half of Prostate Cancer Patients in North Carolina Do Not Receive Multidisciplinary Care
University of North Carolina Health Care System

Only half of the men who receive a prostate cancer diagnosis in North Carolina consult with more than one type of physician before deciding on a course of treatment, according to research presented by University of North Carolina researchers at the 2013 American Society for Radiation Oncology (ASTRO) annual meeting on Sept. 24.

Released: 29-Oct-2013 3:00 PM EDT
Women Benefit From Less-Used Wrist Access Site for Angioplasty
Duke Health

For women who are at high risk of blood loss, using an artery in the wrist may be better than the groin for routing a stent to the heart during coronary angioplasty, according to researchers at Duke Medicine.

Released: 29-Oct-2013 1:00 PM EDT
Experimental Drug Shows Promise in Lung Cancer
University of California, Los Angeles (UCLA), Health Sciences

MK-3475, an anti-PD1 immunotherapy drug with promising results in advanced trials in melanoma is also showing potential in lung cancer based on preliminary phase 1b data presented at the 15th World Conference on Lung Cancer in Sydney, Australia. By blocking the PD-1 protein, the drug alerts the immune system to attack the cancer. It is generally well tolerated and further trials in lung cancer are currently underway.

24-Oct-2013 8:00 PM EDT
High Rate of Lower Back Injuries Reported in Young Athletes
Loyola Medicine

Lower back injuries are the third most common injuries suffered in athletes under age 18. Many injuries are severe enough to sideline young athletes for one-to-six months, and put them at future risk for long-term back problems, a study has found.

Released: 28-Oct-2013 1:05 PM EDT
Overlooked Lymph Nodes in Rib Cage Have Prognostic Power for Mesothelioma Patients
Perelman School of Medicine at the University of Pennsylvania

For the first time, researchers from the Perelman School of Medicine at the University of Pennsylvania have shown the predictive power of a group of overlooked lymph nodes--known as the posterior intercostal lymph nodes--that could serve as a better tool to stage and ultimately treat patients with malignant pleural mesothelioma.

Released: 28-Oct-2013 11:00 AM EDT
Young Fibromyalgia Patients Report Worse Symptoms Than Older Patients
Mayo Clinic

symptoms and poorer quality of life than older patients, a Mayo Clinic study shows. Fibromyalgia most often strikes women. It is characterized by widespread musculoskeletal pain with fatigue, sleep, memory and mood issues. The research, one of several Mayo studies being presented at the American College of Rheumatology annual meeting, suggests the disorder plays out differently among different age groups.

Released: 28-Oct-2013 11:00 AM EDT
Young Children with Asthma Visit Emergency Department Most Often, Fall Months the Busiest
University Hospitals Cleveland Medical Center

New research study finds that children ages 1 to 3 years account for one-fifth of all emergency department visits caused by complications from asthma, representing the highest proportion of visits among asthma patients under age 21. In addition, 55 percent of all ED visits due to asthma occur in boys, and fall months – September, October and November – have a relatively high proportion of visits compared to other times of the year. The research was presented at the American Academy of Pediatrics (AAP) National Conference in Orlando. At AAP, the same research team also presented an analysis of adverse drug events (ADE) among hospitalized children in the U.S. from 2003 to 2010. Results reveal that medication errors and ADEs in pediatric inpatient settings gradually increased between 2003 and 2010, although the cause for this increase requires further study.

22-Oct-2013 9:30 PM EDT
HPV Strains Affecting African-American Women Differ from Vaccines
Duke Health

Two subtypes of human papillomavirus (HPV) prevented by vaccines are half as likely to be found in African-American women as in white women with precancerous cervical lesions, according to researchers at Duke Medicine.

Released: 28-Oct-2013 8:00 AM EDT
Nanomaterials Inventory Improved to Help Consumers, Scientists Track Products
Virginia Tech

Nanotechnologies are growing in commercial use after more than 20 years of research. This new resource gives the public the best available look at more than 1,600 manufacturer-identified, nanotechnology-based consumer products introduced to the market.

23-Oct-2013 2:30 PM EDT
Flawed Health Care System Causes Doctors to “Bend” Ethical Norms to Best Serve Their Patients
Hospital for Special Surgery

A survey among rheumatologists finds many face moral dilemmas when trying to do what’s best for their patients in the current health care environment.

18-Oct-2013 12:00 PM EDT
Impact of Urate-Lowering Therapy on Kidney Disease in People with Hyperuricemia
American College of Rheumatology (ACR)

Urate-lowering therapy alone may not directly reduce the risk of kidney disease in those with hyperuricemia. However, according to a study presented this week at the American College of Rheumatology Annual Meeting in San Diego, working to lower serum uric acid based on the 2012 American College of Rheumatology Guidelines for Management of Gout has a positive effect.

18-Oct-2013 11:50 AM EDT
Smoking Can Increase X-Ray Damage in People with Ankylosing Spondylitis by as Much as Five Times
American College of Rheumatology (ACR)

Smoking can increase the effect of inflammation on X-ray damage in people with ankylosing spondylitis by as much as five times. And, the increase is as much as 13 times higher in men with the disease who smoke than women who don’t smoke, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 11:00 AM EDT
Few Children and Young Adults with Autoimmune Diseases Are Receiving the HPV Vaccination
American College of Rheumatology (ACR)

The number of children and young adults with autoimmune diseases receiving the HPV vaccination is profoundly low despite studies showing the vaccine to be safe and effective, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. Given the increased incidence of HPV in people with autoimmune diseases, this research suggests that increased public health efforts are needed.

18-Oct-2013 11:00 AM EDT
Medication Used to Control Blood Sugar in People with Type 2 Diabetes May Also Reduce the Risk of Autoimmune Diseases
American College of Rheumatology (ACR)

Dipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these patients, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 1:00 PM EDT
Using Tumor Necrosis Factor Inhibitors Decreases Risk of Heart Attacks in Rheumatoid Arthritis Patients
American College of Rheumatology (ACR)

Rheumatoid arthritis patients who use tumor necrosis factor inhibitors (called Anti-TNFs) to control their disease-related inflammation also have a decreased risk for heart attacks, according to research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 1:55 PM EDT
Reduced Need for Joint Surgery in Patients with Rheumatoid Arthritis Over Time
American College of Rheumatology (ACR)

Treating rheumatoid arthritis patients with intensive pharmacological agents, such as biologic drugs, may reduce the need for orthopedic joint surgery, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 2:00 PM EDT
Anti-TNFs Found to Reduce Risk of Acute Coronary Syndrome in Rheumatoid Arthritis Patients
American College of Rheumatology (ACR)

Tumor necrosis factor inhibitor drugs (commonly called Anti-TNFs) modestly reduce the risk of acute coronary syndrome, such as heart attacks and angina, in rheumatoid arthritis patients whose inflammation places them at higher risk of developing coronary heart disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 2:25 PM EDT
Infection Risk Not Increased by Use of Antirheumatic Drugs Prior to Surgery in Patients with Rheumatoid Arthritis
American College of Rheumatology (ACR)

Patients with rheumatoid arthritis may not need to halt use of their antirheumatic drugs prior to surgery due to fears of increased infection risk, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 2:00 PM EDT
Aggressive, Early Intervention with Disease-Modifying Drugs Improves Outcomes for Psoriatic Arthritis Patients
American College of Rheumatology (ACR)

People with psoriatic arthritis who receive early, aggressive pharmacologic intervention following a treat-to-target approach show better outcomes than those who receive standard care, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 3:00 PM EDT
Bracing Improves Pain and Bone Marrow Lesions in Patients with Osteoarthritis of the Knee
American College of Rheumatology (ACR)

Use of a patellofemoral knee brace can improve pain symptoms and bone marrow lesions in patients with a type of osteoarthritis of the knee, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 3:00 PM EDT
Increasing Physical Activity in Adults with or at Risk for Osteoarthritis May Lead to Longer, Higher- Quality of Life with Less Money Spent in Health Care
American College of Rheumatology (ACR)

Osteoarthritis patients who engage in regular physical activity have higher Quality- Adjusted Life Years, a standard measurement of quality of life and cost-effectiveness of medical treatment, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 3:40 PM EDT
Walking Program Shows Promise in Reducing Joint Stiffness in Older Breast Cancer Survivors on Aromatase Inhibitor Therapy
American College of Rheumatology (ACR)

A self-directed walking program shows promise in easing joint stiffness in older women who experienced these symptoms while taking aromatase inhibitor therapy for breast cancer, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 3:00 PM EDT
Telephone Support Helps Knee Osteoarthritis Patients Continue Muscle-Strengthening Exercise Regimen
American College of Rheumatology (ACR)

New research presented at the American College of Rheumatology Annual Meeting in San Diego describes an exciting novel tool utilizing telephone linked technology that shows potential as a low cost approach to improving exercise adherence in patients with knee osteoarthritis. The telephone- linked technology acts as an automated physical trainer and behavior therapist to improve adherence to a strengthening protocol for knee osteoarthritis.

18-Oct-2013 11:20 AM EDT
Aggressive Combination Therapy Helps Children with Juvenile Idiopathic Arthritis Achieve Inactive Disease Faster
American College of Rheumatology (ACR)

Children with juvenile idiopathic arthritis who receive early, aggressive therapy with a combination of medications achieve clinical inactive disease status faster than they would with less aggressive therapy, according to new research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 11:00 AM EDT
Combination DMARDs More Cost-Effective with Comparable Lifetime Results Than Anti-TNF Therapy in Treating Rheumatoid Arthritis
American College of Rheumatology (ACR)

Starting with a combination of three traditional disease-modifying antirheumatic drugs (called DMARDs) for treating early rheumatoid arthritis is more cost-effective long term, with comparable benefits, than using either an immediate or step-up approach with anti-tumor necrosis factor (called Anti-TNFs) drugs and methotrexate, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 11:40 AM EDT
Triple DMARD Therapy Vs. Methotrexate Monotherapy: Which Is Best in Treating Early Rheumatoid Arthritis?
American College of Rheumatology (ACR)

Using a combination of three traditional disease-modifying antirheumatic drugs for treating recent-onset rheumatoid arthritis is more efficient than a monotherapy approach using methotrexate, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Diego.

18-Oct-2013 11:45 AM EDT
Triple DMARD Therapy Is More Cost-Effective Than Methotrexate Monotherapy in Treating Rheumatoid Arthritis
American College of Rheumatology (ACR)

Using a combination of three traditional disease-modifying antirheumatic drugs for treating recent-onset rheumatoid arthritis is not only more cost-effective, but results in better long-term worker productivity than a monotherapy approach using methotrexate, according to new research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 2:00 PM EDT
High Percentage of Rheumatoid Arthritis Patients Discontinue Triple Therapy, Adding or Substituting Other Drugs After Two Years
American College of Rheumatology (ACR)

A high percentage of rheumatoid arthritis patients discontinue triple therapy, a combination of disease-modifying antirheumatic drugs, after one to two years, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 2:00 PM EDT
United States Medicaid Beneficiaries Not Adequately Following Lupus Treatment Plans
American College of Rheumatology (ACR)

Medicaid beneficiaries with lupus are not adequately following their treatment plans, and this puts them at risk for poor health outcomes, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. For most lupus medications, fewer than one in three beneficiaries were found to be adherent.

18-Oct-2013 3:00 PM EDT
New Findings Show Damage Resulting From Lupus Is a Potentially Modifiable Outcome
American College of Rheumatology (ACR)

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.

18-Oct-2013 3:00 PM EDT
Children Whose Mothers Have Lupus Might Be at Increased Risk of Autism Spectrum Disorders
American College of Rheumatology (ACR)

According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, children born to mothers with lupus may be at twice the risk of autism spectrum disorders than those born to mothers without the disease.

18-Oct-2013 3:00 PM EDT
Pregabalin Significantly Improves Fibromyalgia Pain in Patients Who Also Suffer From Depression
American College of Rheumatology (ACR)

Pregabalin (Lyrica® Capsules CV) can significantly improve fibromyalgia pain in people who also are being treated for depression, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 3:00 PM EDT
Common Rheumatoid Arthritis Treatment May Be Effective in Treating Immunoglobulin G4-Related Disease
American College of Rheumatology (ACR)

Rituximab (Rituxan®) — a drug commonly used rheumatoid arthritis, granulomatosis with polyangiitis (formerly Wegener’s), and certain types of cancers — may be a safe and effective treatment for immunoglobulin G4-related disease (commonly called IgG4-RD), according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 3:00 PM EDT
New Tools in Juvenile Arthritis Treatment Help Children, Their Families and Their Rheumatologists Share in Important Health Care Decision Making
American College of Rheumatology (ACR)

Learning that your child has arthritis can lead to a number of questions and concerns about treatment options and prognosis. But, partnering with your child and his or her rheumatologist in shared decision making about their health care can lead to better outcomes overall, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

18-Oct-2013 3:00 PM EDT
Recent Advances in Medicine Lead to Better Health for Children with Juvenile Arthritis
American College of Rheumatology (ACR)

There has been a progressive decline in the levels of disease activity and disability among children with juvenile idiopathic arthritis over the past 25 years, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. This research confirms the notion that recent advances in the management of the disease have led to a substantial improvement in health outcomes for children living with it.

18-Oct-2013 3:00 PM EDT
New Oral Treatment Shows Significant Promise in the Treatment of Mouth and Genital Ulcers in People with Behcet’s Syndrome
American College of Rheumatology (ACR)

Apremilast, an orally available small molecule modulating several inflammatory pathways, which is pending approval by the United States Food and Drug Administration, is showing promise in the treatment of mouth and genital ulcers in people with Behcet’s syndrome, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Diego.

22-Oct-2013 10:00 AM EDT
Rheumatoid Arthritis and Heart Disease: Mayo Clinic Studies Shed Light on Dangerous Connection
Mayo Clinic

People with rheumatoid arthritis and other chronic inflammatory conditions are at higher risk of heart disease. Who is in the most danger, why and how best to prevent and detect cardiovascular complications are important questions for physicians and researchers.

23-Oct-2013 3:30 PM EDT
People Who Are Socially Isolated Experience More Pain After Hip Replacement
Hospital for Special Surgery

Researchers at Hospital for Special Surgery found that people who lacked good social connections were much more likely to experience serious, ongoing pain following total hip replacement surgery two or more years after the procedure.

23-Oct-2013 5:00 PM EDT
Study Shows How Social Media Engages People with Chronic Diseases
Hospital for Special Surgery

Using Facebook chats to convey health information is becoming more common. A study at Hospital for Special Surgery (HSS) in New York City set out to find the best way to boost participation in the chats to raise awareness of lupus, an autoimmune disease.

23-Oct-2013 5:00 PM EDT
Timely, Effective Treatment of Rheumatoid Arthritis Reduces Disability Two Years Out
Hospital for Special Surgery

Delaying treatment for rheumatoid arthritis could greatly increase the likelihood that patients will suffer joint damage and experience disability two years out, according to a new study from Hospital for Special Surgery.

23-Oct-2013 5:20 PM EDT
Study Identifies Biomarker Linked to Poor Outcomes in Pregnant Lupus Patients
Hospital for Special Surgery

Pregnant women who have lupus are at increased risk of adverse outcomes. Researchers at Hospital for Special Surgery in New York City have identified a biomarker that may predict who is most at risk.

21-Oct-2013 7:15 AM EDT
“High-Risk” Organs From Deceased Donors Safe When Screened with Current Methods
American Society of Nephrology (ASN)

Highlights • After a median of 2.4 years of follow up, 86.5% of transplants of donor kidneys considered “high-risk” for infection and disease were functioning with no evidence of infections. • Such “high-risk” organs are relatively safe when screened with current methods.

18-Oct-2013 10:00 AM EDT
Stopping Transplant Drugs Before Conception Benefits Fetus
American Society of Nephrology (ASN)

Highlights • Kidney transplant recipients who discontinue immunosuppressive drugs before conception have a higher rate of live births and a lower rate of birth defects without an increased risk of kidney problems.

Released: 23-Oct-2013 4:00 PM EDT
Penn Doctors Find Successful Strategy to Improve Patient Participation in Hard-to-Enroll Clinical Trials
Perelman School of Medicine at the University of Pennsylvania

Results from a willingness to participate study, led by Charles B. Simone, MD, chief of Thoracic Oncology and assistant professor of Radiation Oncology at Penn’s Abramson Cancer Center, found that focusing on particular factors—including hope for positive outcomes, randomization and altruism— and increasing the time spent with patients increased their likelihood of participating in a clinical trial for malignant pleural mesothelioma (MPM), a rare cancer often diagnosed in people who have been exposed to high levels of asbestos.

Released: 23-Oct-2013 2:00 PM EDT
Birthing a New Breed of Materials
AVS: Science and Technology of Materials, Interfaces, and Processing

Research presented at the AVS Meeting in Long Beach, Calif. shows scientists’ first steps into the unexplored territory of interfacial materials that could someday yield smaller, faster, more energy-efficient devices.

Released: 23-Oct-2013 12:10 PM EDT
Mayo Clinic Experts: What Should You Know About E-cigarettes?
Mayo Clinic

E-cigarettes are becoming increasingly popular and widely available as the use of regular cigarettes drops. Recently, the Centers for Disease Control and Prevention (CDC) reported that e-cigarette use by children doubled from 2011 and 2012. The health effects of e-cigarettes have not been effectively studied and the ingredients have little or no regulation. Mayo Clinic’s Nicotine Dependence Center experts are available to discuss what people should know before trying e-cigarettes.

Released: 23-Oct-2013 8:00 AM EDT
Could a ‘Trojan Horse’ Better Identify Traumatic Brain Injury?
University of Virginia Health System

Accurately diagnosing traumatic brain injuries (TBI) and concussions is difficult, as standard CT or MRI scans can’t see most changes to the brain caused by these injuries. Borrowing a tactic used to identify lung infections, University of Virginia School of Medicine researchers have discovered a potential method to identify TBI that uses positron emission tomography (PET) scans and the body’s immune response to a brain injury.



close
1.84106